An Open Phase II Study To Evaluate The Efficacy And Toxicity Of Topotecan Administered Intravenously As Five Daily Infusions Every 21 Days To Women With Advanced Epithelial Ovarian Carcinoma

Update Il y a 5 ans
Reference: GSK104864/012

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract


Links